Imfinzi (durvalumab) - AstraZeneca
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Keytruda (pembrolizumab) - Merck (MSD)
Tevimbra (tislelizumab-jsgr) - BeOne Medicines
AiRuiKa (camrelizumab) - Elevar Therapeutics
Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Bioscience, Coherus Oncology
Tyvyt (sintilimab) - Innovent Biologics, Eli Lilly
https://acg2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=R01PT1FGR0UyNjkyNQ&PosterID=833129&rnd=0.6004875
 
Mohamad Mahfouz MD 1; Maikel Tawadrous MD 2; Muhammad Sarfraz Khan MD 3; Pradeep Rajbhandari MD 4; Shahzaib Maqbool MD 5; Archana Machavarapu MD 6
 
Aug 29, 2026
 
Prev Next